[Adjuvant chemotherapy with carminomycin and bleomycetin after radical surgery for squamous cell carcinoma of the lung (preliminary communication)].
D000328:Adult; D000368:Aged; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use* / Q000031:analogs & derivatives; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000601:surgery; D002360:Carubicin / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003630:Daunorubicin / Q000031:analogs & derivatives*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D001761:Bleomycin; C025703:bleomycetin; D002360:Carubicin; D008727:Methotrexate; D003630:Daunorubicin
Ispol'zovanie karminomitsina i bleomitsetina dlia dopolnitel'noĭ khimioterapii posle radikal'nykh operatsiĭ po povodu ploskokletochnogo raka legkogo (predvaritel'noe soobshchenie).